Frontlight ResearchEarly access
Trial site
Eastern Regional Medical Center
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Colorectal cancer3 trials
- Liver and biliary tract cancer3 trials
- Bladder cancer2 trials
- Ovarian cancer2 trials
- Pancreatic cancer2 trials
- Prostate cancer2 trials
- Sarcoma2 trials
- Thyroid cancer2 trials
- Triple-negative breast cancer2 trials
- Cervical cancer1 trial
- Endometrial cancer1 trial
- and 7 more
- Phase
- Phase 36 trials
- Phase 23 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting6 trials
- Completed3 trials
- Terminated2 trials
- Lead sponsor
- National Cancer Institute (NCI)7 trials
- NRG Oncology2 trials
- Alliance for Clinical Trials in Oncology1 trial
- SWOG Cancer Research Network1 trial
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Active, not recruiting
Active, not recruiting
Closed trials
Completed
Terminated
Terminated
Completed
Completed
Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
Site data: ClinicalTrials.govUpdated 17 Nov 2026